June 25, 2018
PHILADELPHIA (Embargoed until 10 AM EDT, Monday, June 25, 2018) – Vasken Dilsizian, MD, professor of radiology and medicine at the University of Maryland School of Medicine and chief of the Division of Nuclear Medicine at the University of Maryland Medical Center in Baltimore, Maryland, has assumed office as 2018-19 president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2018 Annual Meeting, June 23–26 in Philadelphia, Pennsylvania.
Reflecting on his focus in the year ahead, Dilsizian stated, “The indispensable factor of sustaining any field of science or intellectual endeavor is the influx of new ideas and solutions to previously unsolved—but in principle solvable—problems. The most fruitful areas of growth in nuclear medicine are those that have been neglected between the various established imaging disciplines. It is within these neglected boundaries that targeted radionuclide-based imaging offers the greatest opportunities for growth.” He pointed out, “Last year we witnessed the approval of two diagnostic and one therapeutic radiopharmaceutical agents by the FDA, which was a tall order.”
Dilsizian added, “Given the various internal medicine subspecialties represented within the SNMMI, the Society should cast a wide net and cultivate opportunities for collaboration with the other professional organizations, underscoring the value of molecular imaging for patient management, promoting additional subspecialty nuclear medicine training, and fostering scientific investigations. The clinical translation of new diagnostic and therapeutic radiopharmaceuticals and their integration into patient management and appropriate use guidelines is the very vital lifeline of our organization. Such developments would ensure the SNMMI’s survival in the new millennium.”
His additional goals include partnering with other international organizations in order to strengthen the SNMMI’s advocacy efforts and increasing international membership to promote SNMMI as an international leading scientific and educational society.
Dilsizian graduated from Tufts University School of Medicine in 1982. This was followed by an internal medicine residency at Georgetown University School of Medicine in 1985, a fellowship in Cardiology at Boston University Medical Center and Massachusetts General Hospital in 1988, and a nuclear medicine residency at the National Institutes of Health in 1992. He holds master's (Tau Beta Pi) and bachelor's (magna cum laude) degrees in chemical engineering, both from Tufts University. He is a diplomate of the American Board of Internal Medicine, Cardiovascular Diseases, and Nuclear Medicine.
Dilsizian has been involved in many councils, committees, and task forces at SNMMI as well as the American College of Cardiology, American Heart Association, and American Society of Nuclear Cardiology (ASNC). He served as president of the Cardiovascular Council of the SNMMI (2013-2014) and was awarded the 2014 Hermann Blumgart Award for his contributions to the science of nuclear cardiology. He was the SNMMI Henry N. Wagner, Jr., Cardiovascular Nuclear and Molecular Imaging Lecturer in 2014 and 2015. He is on the board of directors of the SNMMI and ASNC and was program chair for the ASNC 2014 scientific sessions. In 2016, he became a Master of the American Society of Nuclear Cardiology for his contributions to the field of nuclear cardiology and for holding senior leadership positions within the society. He was chair of the American College of Cardiology (ACC) Task Force on clinical competence and training in nuclear cardiology. He serves on the Advisory Committee on the Medical Uses of Isotopes for the Nuclear Regulatory Commission (2014-2022). In addition, he is serving a four-year term (2018-2022) on the Board of Scientific Counselors of the Clinical Center of the National Institutes of Health.
Dilsizian spent 13 years at the National Institutes of Health, where he served as director of nuclear cardiology from 1992 to 2001. His research efforts over the past 30 years have culminated in more than 215 original, peer-reviewed manuscripts and invited editorials/articles, 10 books and 43 book chapters. He has served as a guest editor on five periodicals and excerpts. He serves as deputy editor of the Journal of American College of Cardiology—Cardiovascular Imaging, section editor of the Journal of the American College of Cardiology, and the editorial board of The Journal of Nuclear Medicine. He is a co-editor of the Atlas of Nuclear Cardiology (now in its 5th edition), Cardiac CT, PET and MR (now in its 3rd edition) and, most recently, the Atlas of Cardiac Innervation. He has also been a co-author of the “Nuclear Cardiology” chapter in Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine since 2005.
Other SNMMI officers elected for 2018-19 are Satoshi Minoshima, MD, PhD, Salt Lake City, Utah, as president and Alan B. Packard, PhD, Boston, Massachusetts, as vice president-elect. SNMMI Technologist Section officers for 2018-19 are Norman E. Bolus, MSPH, CNMT, FSNMMI-TS, Birmingham, Alabama, as 2018-19 SNMMI-TS president and Mark H. Crosthwaite, MEd, CNMT, PET, FSNMMI-TS, Richmond, Virginia, as president-elect.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.